ASSEMBLY APPROPRIATIONS COMMITTEE
STATEMENT TO
[First Reprint]
ASSEMBLY, No. 5000
with committee amendments
STATE OF NEW JERSEY
DATED: JUNE 19, 2025
The Assembly Appropriations Committee reports favorably and with committee amendments Assembly Bill No. 5000 (1R).
As amended, this bill requires the State Medicaid program and the Plan First program to cover standard fertility preservation services in cases in which a medically necessary medical treatment may directly or indirectly cause iatrogenic infertility. The amended bill limits the provision of fertility preservation services to one fertility preservation cycle, unless the procedure is unsuccessful.
The State’s Plan First program provides a benefit package of family planning and family planning-related services and supplies for individuals whose annual incomes are below 205 percent of the federal poverty level and who are not otherwise eligible for Medicaid or the NJ FamilyCare program.
The bill defines “iatrogenic infertility” as an impairment of fertility caused by surgery, radiation, chemotherapy, or other medical treatment affecting reproductive organs or processes. The bill further defines “standard fertility preservation services” as procedures which are consistent with established medical practices and professional guidelines published by the American Society for Reproductive Medicine, the American Society of Clinical Oncology, or as defined by the New Jersey Department of Health.
The bill will provide Medicaid and Plan First participants who face iatrogenic infertility with access to fertility preservation services that are frequently cost-prohibitive for low-to-moderate income patients.
COMMITTEE AMENDMENTS:
The committee amendments limit fertility preservation services to one fertility preservation cycle, unless that procedure is unsuccessful.
FISCAL IMPACT:
The OLS determines that annual State Medicaid expenditures will increase by an indeterminate amount annually to cover standard fertility preservation services for Medicaid and Plan First enrollees of reproductive age who are diagnosed with iatrogenic infertility. Given that 95 percent of the State’s Medicaid beneficiaries are enrolled in a managed care plan, and the State’s contract with the Medicaid managed care organizations specifically precludes coverage for services provided primarily for the diagnosis and treatment of infertility, the OLS lacks the informational basis to determine by what amount State costs will increase under the bill.
Any increase in State Medicaid expenditures will increase State revenues, albeit by an indeterminate amount, in the form of federal reimbursements for State Medicaid expenditures under the federal Medicaid program.